Corey May picked up by Certain Affinity as narrative director

Assassin’s Creed writer quits Ubisoft

One of the scriptwriters behind the Assassin’s Creed series has left Ubisoft to take up a new role at Texas-based studio Certain Affinity.

Corey May joins the team as narrative director as Certain Affinity shifts towards developing triple-A games and original IP. Prior to this, Certain Affinity focused on co-development.

May’s credits include Assassin’s Creed I to III and Brotherhood, as well as Army of Two, Prince of Persia: The Two Thrones and Batman: Arkham Origins. He has also written scripts for multiple films.

“Joining Certain Affinity is a once-in-a-lifetime opportunity,” he said in a statement. “The projects are so interesting and intriguing… but it is the entire company team that is the real draw. There’s just so much talent and passion on display here – it’s infectious.”

Certain Affinity president Max Hoberman added: “I’m thrilled to welcome Corey to Austin and Certain Affinity. This is the first of several key new leadership positions aimed at helping us evolve from a co-developer into a full-blown developer of triple-A console and PC games.

“While multiplayer will continue to be an important part of our DNA and our project portfolio, we’re also intent on becoming experts at single-player and co-operative experiences. Best-in-class talent like Corey building and leading our narrative department is a huge leap in this direction, and his experience and perspective will be tremendous assets to us.”

About MCV Staff

Check Also

g2a logo black bg 1 [Industry news] G2A.COM’s Autonomous AI Agent Dave Helps Sellers Resolve 14,400 Support Tickets in 63 Days

[Industry news] G2A.COM’s Autonomous AI Agent Dave Helps Sellers Resolve 14,400 Support Tickets in 63 Days

G2A.COM, the world’s largest digital marketplace, today announced the global launch of ‘Dave’, its proprietary autonomous customer support agent, which will be available to sellers operating on the platform, following a highly successful two-month trial period.